News

NanoGroup Share Issue Price in the Auxilius Pharma Transaction Set at PLN 4.20

Under the investment agreement concluded with Auxilius Pharma, the parties agreed on an issue price of PLN 4.20 per NanoGroup share. Auxilius Pharma shareh…

Key Shareholders of NanoGroup and Auxilius Pharma to Be Subject to an 18-Month Lock-Up

Key Shareholders of NanoGroup and Auxilius Pharma to Be Subject to an 18-Month Lock-Up

NanoGroup’s largest shareholders subject to an 18-month lock-up Under the investment agreement concluded for the merger of NanoGroup and Auxilius Pharma, t…

NanoGroup One Step Away from Fully Integrating Auxilius Pharma into Its Group

NanoGroup S.A. has reached a major milestone on the path towards consolidating the market. The Company has signed an investment agreement with Auxiliu…

Selection of the NanOX 4 Kidney Formulation for Further Studies – A Key Milestone in Project Development

NanoSanguis S.A., a company within the NanoGroup S.A. group, has completed the selection process for the NanOX 4 Kidney perfusion fluid formulation. The de…

NanoSanguis Signs Agreement with SyVento to Support the Development and Quality-Compliant Manufacturing of NanOX 4 Kidney Perfusion Fluid

On 13 May 2026, NanoSanguis S.A.’s subsidiary entered into an agreement with SyVento sp. z o.o., formally launching the industrial development phase o…

Selection of a Contract Manufacturer for the NanOX 4 Kidney Project

As part of project FENG.01.01-IP.02-1136/24 – “NanOX 4 Kidney – A Next-Generation Kidney Perfusion Fluid Based on a Synthetic Oxygen Carrier…

Media resources

Company logo

logotype.zip (1.27 MB)
Download
pp-thumbnail